Stock comparison
Mettler-Toledo International
TransMedics Group
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
TMDX
TransMedics Group
Market cap
$2.38B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | TMDX | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 55D | MTD |
| Benjamin Graham | 65B | 61D | MTD |
| Philip Fisher | 63C | 56C | MTD |
| Peter Lynch | 66B | 84C | TMDX |
| Joel Greenblatt | 68B | 48D | MTD |
| Charlie Munger | 74B | 54D | MTD |
| Terry Smith | 70B | 47D | MTD |
Side-by-side metrics
| Metric | MTD | TMDX |
|---|---|---|
| Market cap | $22.29B | $2.38B |
| P/E (TTM) | 25.3x | 12.6x |
| EV/EBIT | 21.6x | 23.4x |
| ROIC (TTM) | 36.09% | 6.94% |
| Gross margin | 57.79% | 59.09% |
| Net margin | 21.4% | 27.04% |
| Revenue CAGR 5y | 2.01% | 111.5% |
| EPS CAGR 5y | 6.12% | - |
| Debt / Equity | - | 1.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 1.7x+103%
- Market cap$22.29Bvs $2.38B+89%
- ROIC (TTM)36.09%vs 6.94%+81%
- EV/EBIT21.6xvs 23.4x+8%
TMDX leads on
- Revenue CAGR 5y111.5%vs 2.01%+98%
- P/E (TTM)12.6xvs 25.3x+50%
- Net margin27.04%vs 21.4%+21%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.